TrialThe American journal of cardiology2022

Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial).

Ellen C Keeley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.